Quantcast
Weekly Text Message Could Encourage Healthier Food Choices

Weekly Text Message Could Encourage Healthier Food Choices, New Study Shows

Andrea Maruniak, Johns Hopkins University Bloomberg School of Public Health Many people are unaware that the U.S. Food and Drug Administration’s mandated nutrition labels are based on a 2,000-calorie-a-day diet, but a simple weekly text...

Latest U.S. Food and Drug Administration Stories

2014-09-18 23:13:39

Xarelto® drug takers allege adverse medical events, such as uncontrolled bleeding and wrongful deaths, occurred after taking the blood clot prevention drug. Glen Lerner Injury Attorneys announce they now offer free class action claim reviews against drug manufacturers from those who believe they were injured after taking the drug and not properly warned about the increased potential for serious and irreversible bleeding risks due to lack of reversal agent. U.S.A. (PRWEB) September 18,...

2014-09-18 08:30:19

- Richards Teams Up with Allergan, the Makers of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, to Raise Awareness of the Disease - IRVINE, Calif., Sept. 18, 2014 /PRNewswire/ -- TV personality, fashion entrepreneur and star of the "Real Housewives of Beverly Hills" Kyle Richards is partnering with Allergan, the makers of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, to raise awareness of Chronic Dry Eye. As many as 25 million people in the United States report suffering...

2014-09-18 08:28:59

- Spectrum receives a 19.99% stake (pre-transaction) in CASI, a NASDAQ-listed, oncology-focused Company with expertise and focus on markets in China and a $1.5 million promissory note HENDERSON, Nev. and ROCKVILLE, Md., Sept. 18, 2014 /PRNewswire/ -- Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, and CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a...

2014-09-17 20:22:10

OTTAWA, Sept. 17, 2014 /CNW/ - Health Canada has taken the precautionary step of asking IPCA Laboratories in India to voluntarily stop shipment of products to Canada based on a review of a recent good manufacturing practices (GMP) inspection report by the U.S. Food and Drug Administration (FDA) where they identified falsification and manipulation of data issues at the company. IPCA has not disputed the FDA findings with Health Canada. The FDA has not issued a recall of any of the...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-17 08:31:00

HAYWARD, Calif., Sept. 17, 2014 /PRNewswire/ -- Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the RYTARY(TM) (IPX066) New Drug Application (NDA) from October 9, 2014, to January 9, 2015. The Company amended the chemical, manufacturing and control (CMC) section of the RYTARY NDA subsequent to...

2014-09-16 20:27:17

-- Survey Data Requested by FDA for the September 26 Patient-Focused Drug Development Meeting for Idiopathic Pulmonary Fibrosis CHICAGO, Sept. 16, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that it has submitted survey data from more than 1,100 patients and families suffering from pulmonary fibrosis (PF) to the U.S. Food and Drug Administration (FDA) for the Patient-Focused Drug Development Meeting for Idiopathic Pulmonary Fibrosis on...

2014-09-14 20:20:15

Analysis From SHIFT Study Shows Ivabradine Reduced Cardiovascular Death or Hospitalization for Worsening Heart Failure Independent of Baseline Blood Pressure With Similar Safety Profile Across Groups THOUSAND OAKS, Calif., Sept. 14, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18(th)...

2014-09-12 12:25:14

SILVER SPRING, Md., Sept. 12, 2014 /PRNewswire-USNewswire/ -- To help kids make healthful dietary choices, the U.S. Food and Drug Administration encourages kids to Read the Label! To view the multimedia assets associated with this release, please click http://www.multivu.com/players/English/7106353-fda-national-childhood-obesity-month/ The Nutrition Facts Label is a simple tool available on food and beverage packages. It lets kids know exactly what they're eating and helps them choose and...

2014-09-10 12:28:10

The Emergence of Keytruda--the First PD-1 Inhibitor Approved in the U.S.--is a Significant Milestone in Oncology, According to Decision Resources Group BURLINGTON, Mass., Sept. 10, 2014 /PRNewswire/ -- The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.